Related Experiment Videos
Control of cell proliferation by embryonal-origin factors
E R Barnea1, J D Barnea, M Pines
1Biospectrum Medical Corporation, Cherry Hill, New Jersey, USA.
Summary
Human embryo extracts contain factors that inhibit cancer cell growth. These compounds show potential for treating cancer and other proliferative disorders.
Area of Science:
- Developmental Biology
- Cancer Biology
- Biochemistry
Background:
- Embryogenesis and cancer share rapid cell proliferation, but embryogenesis maintains a balance of proliferative and anti-proliferative signals.
- Cancerous cell proliferation lacks the regulatory control seen in normal development.
Purpose of the Study:
- To identify and characterize factors from human embryonal neural tissue that suppress cancer cell proliferation.
- To evaluate the therapeutic potential of these embryonal factors.
Main Methods:
- Chromatographic separation of human embryonal neural tissue extracts.
- Assessing anti-proliferative effects on human breast cancer cells and other cell lines (osteosarcoma, fibrosarcoma, Balb/c 3T3).
- Measuring cell number, viability, and [3H]-thymidine incorporation.
- SDS-PAGE analysis of active fractions.
Main Results:
- Two distinct fractions from human embryo extracts significantly suppressed human breast cancer cell proliferation (up to 70% inhibition).
- Inhibition was time-dependent and maintained cell viability, confirmed by reduced [3H]-thymidine incorporation.
- Active fractions demonstrated cross-species effectiveness, inhibiting mouse and rat cell lines.
Conclusions:
- Human embryonic neural tissue contains potent factors that inhibit malignant cell proliferation.
- These novel embryonal factors warrant further investigation for therapeutic applications in cancer and proliferative diseases.